3.8
Bacteriële meningitis II: Pathofysiologie
Bacteriële meningitis begint meestal wanneer pathogenen zoals Neisseria meningitidis en Streptococcus pneumoniae de nasofarynx koloniseren en de bloed…
Bacterial meningitis begins when pathogens such as Neisseria meningitidis colonize the nasopharynx and invade the bloodstream, eventually reaching the cerebral vessels.
They penetrate the blood–brain or blood–CSF barriers through the vascular endothelium or the choroid plexus and reach the subarachnoid space.
In this region, the immune responses are tightly regulated, allowing bacteria to multiply and trigger a strong inflammatory response, activating microglia and astrocytes.
These cells secrete proinflammatory cytokines, which increase the expression of adhesion molecules and recruit neutrophils into the cerebrospinal fluid.
The resulting inflammatory response disrupts the blood-brain barrier, causing vasogenic and cytotoxic edema that elevates intracranial pressure and reduces cerebral perfusion.
In some cases, vascular inflammation triggers endothelial activation and neutrophil-mediated injury, which may promote microthrombi formation, reducing cerebral blood flow and causing ischemic neuronal damage.
This cascade of barrier disruption, edema, and vascular injury leads to the rapid progression of bacterial meningitis.
View the full transcript and gain access to JoVE Core videos
Q1: How do bacteria reach the central nervous system in bacterial meningitis?
Bacteria such as Neisseria meningitidis colonize the nasopharynx and invade the bloodstream, eventually reaching cerebral vessels. They penetrate the blood-brain barrier or blood-cerebrospinal fluid barrier through the vascular endothelium or choroid plexus to reach the subarachnoid space. Bacterial virulence factors like polysaccharide capsules help resist immune defenses during this invasion.
Q2: What role do microglia and astrocytes play in bacterial meningitis pathophysiology?
Bacterial components like lipopolysaccharides and teichoic acids trigger activation of microglia and astrocytes in the subarachnoid space. These cells secrete proinflammatory cytokines including TNF-α, IL-1β, and IL-6, which increase adhesion molecule expression and recruit neutrophils into the cerebrospinal fluid, amplifying the inflammatory cascade.
Q3: How does inflammation disrupt the blood-brain barrier in meningitis?
Proinflammatory cytokines increase vascular permeability, causing vasogenic edema as plasma leaks into the extracellular space. Cytotoxic edema develops from inflammatory injury causing intracellular swelling of neurons and glia. Interstitial edema results from impaired cerebrospinal fluid reabsorption at arachnoid villi, collectively elevating increased intracranial pressure and impairing cerebral perfusion.
Q4: What is the relationship between vascular inflammation and neuronal damage in bacterial meningitis?
Vascular inflammation triggers endothelial activation and neutrophil-mediated injury, promoting microthrombi formation that reduces cerebral blood flow. This vascular injury causes ischemic neuronal damage by limiting oxygen delivery to brain tissue. The combination of barrier disruption, edema, and reduced perfusion creates a cascade leading to rapid disease progression.
Q5: Why is the subarachnoid space particularly vulnerable to bacterial proliferation?
The subarachnoid space has limited immune surveillance, allowing bacteria to multiply rapidly after crossing the blood-brain barrier. Cerebrospinal fluid lacks robust antimicrobial defenses compared to blood, enabling bacterial components to accumulate and trigger intense local inflammation. This environment facilitates the pathogenic cascade characteristic of bacterial meningitis.
Q6: What are the three types of edema that develop during bacterial meningitis?
Vasogenic edema occurs from increased vascular permeability allowing plasma leakage into extracellular space. Cytotoxic edema results from inflammatory injury causing intracellular swelling of neurons and glia. Interstitial edema develops from impaired cerebrospinal fluid reabsorption at arachnoid villi due to inflammatory exudates, potentially contributing to hydrocephalus.
Q7: How do bacterial virulence factors contribute to meningitis development?
Bacterial virulence factors such as polysaccharide capsules resist phagocytosis and complement-mediated killing, enabling pathogens to survive in the bloodstream and reach the central nervous system. Once in the subarachnoid space, bacterial components like lipopolysaccharides and teichoic acids trigger immune activation, initiating the inflammatory cascade that characterizes meningitis pathophysiology.